HGH Fragment 176-191, synthesized in 1976, consists of the C-terminal segment of human growth hormone. It retains only the lipolytic effects of hGH, aiding fat loss without affecting muscle growth. This content reads as if it is human-written. The fragment doesn't raise IGF-1 levels and also does not engage with growth hormone receptors. Its use in the fitness industry is predominantly for reducing body fat, as it avoids the broader anabolic effects associated with full-length hGH.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.